New York, New York (PRWEB) March 24, 2013
Bernstein Liebhard LLP notes that the federal judge overseeing Pradaxa lawsuits in a federal multidistrict litigation in U.S. District Court, Southern District of Illinois has scheduled the litigation’s next status conference for April 15th at 1:00 p.m., according to the calendar posted on the court's website. According to court records, more than 170 lawsuits have been filed in the Pradaxa litigation on behalf of individuals who allegedly suffered life-threatening episodes of Pradaxa bleeding. The litigation’s first trials are scheduled to begin in September 2014. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“We continue to hear from individuals who allegedly suffered frightening Pradaxa side effects. We are pleased to see this litigation moving forward,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Pradaxa lawsuit evaluations to victims of alleged Pradaxa bleeding.
Pradaxa Side Effects
Pradaxa was approved for sale by the U.S. Food & Drug Administration (FDA) in October 2012 to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation. According to a recent Bloomberg.com report, the FDA received reports of 542 deaths and 3,781 side-effect incidents tied to the drug in 2011.* One of the major issues with Pradaxa is the fact that there exists no readily available antidote for internal bleeding that can sometimes occur in patients treated with the drug. Dialysis can be used to remove Pradaxa from the blood stream. However, a study published last May in the journal, Neurology, found this treatment is risky and may not be administered in enough time to stop this potentially deadly Pradaxa side effect.** According to a recent QuarterWatch Report from the Institute for Safe Medicine Practices (ISMP), an analysis of hemorrhage cases reported to the FDA during the second quarter of 2012 found that Pradaxa bleeding is 5 times more likely to result in death compared to warfarin bleeding.***
According to Bloomberg.com, regulators in several countries have issued Pradaxa side effect alerts since the drug was first brought to market. Most recently, the FDA released a Drug Safety Communication announcing a new contraindication was being added to the Pradaxa label to warn against its use in patients with mechanical heart valves. The FDA acted after participants in a study who were treated with the blood thinner experienced more strokes, heart attacks, and blood clots forming on the mechanical heart valves compared to users of warfarin. There was also more bleeding reported in Pradaxa patients after valve surgery compared to those treated with warfarin, according to the agency.*****
Victims of serious Pradaxa side effects may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. To learn more about filing a Pradaxa lawsuit, please visit Bernstein Liebhard LLP’s website, http://www.consumerinjurylawyers.com, or call 1-877-779-1414 to speak with an attorney today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com